Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/15138475

Br. J. Cancer 2004 May 17 90 10 1942-8

Download in:

View as

Triples

General Info

PMID
15138475